FDA label
What is cabergoline used for?
The FDA-approved uses of cabergoline, quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “Cabergoline tablets is an ergot derivative indicated for the treatment of hyperprolactinemic disorders, either idiopathic or due to pituitary adenomas in adults.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted cabergoline?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Cabergoline, tablet
Indications and Usage, quoted from the label by Cranbury Pharmaceuticals, LLC (ANDA220309). Cross-references to other label sections are left out.
Cabergoline tablets is an ergot derivative indicated for the treatment of hyperprolactinemic disorders, either idiopathic or due to pituitary adenomas in adults.
Limitations of Use
Avoid use of cabergoline tablets for the inhibition or suppression of postpartum physiologic lactation because of the risk of serious adverse reactions.
Source: DailyMed label, set id 8562f94f-a59a-4893-aefc-ea6547b01e92, version 4, effective June 22, 2026. NDC 27808-315, one of 11 listings for this product.
Questions
What is cabergoline used for?
The FDA label says: “Cabergoline tablets is an ergot derivative indicated for the treatment of hyperprolactinemic disorders, either idiopathic or due to pituitary adenomas in adults.”
What drug class is cabergoline?
FDA lists cabergoline in the Ergot Derivative established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.